Cormorant Global Healthcare Master Fund, LP, 10% Owner, Director at Biomea Fusion, Inc. (BMEA), bought 400,000 shares at $30.00 ($12.0M) on 2023-03-30, disclosed to the SEC on 2023-04-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| DRUG | BUY | 2024-10-17 | $6.4M | — | Filing → |
| CRBP | BUY | 2024-09-24 | $14.0M | — | Filing → |
| EYPT | BUY | 2024-04-22 | $21.0M | — | Filing → |